Oncology: What You May Have Missed in 2024

Area of Science:

• Oncology
• Internal Medicine
• Cancer Therapeutics

Background:

• Over 50 years, oncology has seen significant progress, impacting cancer patient care.
• Internal medicine physicians are integral throughout the patient's cancer journey, from initial screening to long-term surveillance.

Purpose of the Study:

• To review 10 landmark studies from 2024 in oncology.
• To highlight emerging therapies and evolving clinical standards in cancer treatment.
• To emphasize the role of internal medicine in managing complex cancer care.

Main Methods:

• Review of 10 landmark oncology studies published in 2024.
• Analysis of emerging therapies including immunotherapy, targeted therapies, and antibody-drug conjugates.
• Evaluation of advances in supportive care and symptom management.

Main Results:

• Immunotherapy, particularly checkpoint inhibitors, is expanding its application in solid tumors across various stages.
• Targeted therapies and antibody-drug conjugates offer enhanced precision treatment for metastatic cancers.
• Supportive care innovations like MRI-guided prostate screening and agents for cachexia and pain improve patient quality of life.

Conclusions:

• Internal medicine physicians are crucial in multidisciplinary cancer care, co-managing patients and monitoring treatment toxicities.
• Staying abreast of novel oncologic therapies is essential for internal medicine physicians to optimize patient care and outcomes.
• Recent advances in cancer treatment underscore the importance of integrating new therapies while managing their challenges effectively.